96 results
Page 2 of 5
8-K
EX-99.1
51wm4m8414s4t
10 Nov 21
Adicet Reports Third Quarter 2021 Financial Results and Provides Business Updates
4:12pm
8-K
EX-99.1
pzwmlg5a
13 Sep 21
Regulation FD Disclosure
8:14am
8-K
sgvqh88c 6njyz
13 Sep 21
Regulation FD Disclosure
8:14am
8-K
EX-99.1
2sfwkxoiuu66 uflcii
10 Mar 21
Adicet Bio Announces Initiation of its First-in-Human Phase 1 Trial of ADI-001 for Company’s lead candidate, ADI-001, is believed to be the first IND-cleared allogeneic
7:30am
424B5
wozk2yq4kloa7x
11 Feb 21
Prospectus supplement for primary offering
5:20pm
424B5
tuez1wkdmfi0 i5yz
10 Feb 21
Prospectus supplement for primary offering
12:00am
424B5
bou2qx
1 Dec 20
Prospectus supplement for primary offering
5:28pm
8-K
EX-99.1
ee2d n3efwgqwx1dol
22 Oct 20
Adicet Announces FDA Clearance of IND Application for First-in-Class Allogeneic CAR Gamma-Delta T Cell Therapy
7:15am
424B5
p1io1 55asu
21 Sep 20
Prospectus supplement for primary offering
7:58am
8-K
EX-99.1
s9gadqctb
18 Sep 20
Management Following the Merger
4:30pm
8-K
EX-10.30
5vuw7p9
16 Sep 20
Entry into a Material Definitive Agreement
9:59am
8-K
EX-99.6
n7hscj 74iyfn
16 Sep 20
Entry into a Material Definitive Agreement
9:59am